Results 231 to 240 of about 339,703 (317)

Living Microbial Drugs

open access: yesChemistry – A European Journal, EarlyView.
The introduction outlines the review scope. Microbial cell factories as living drugs cover host–gut microbiota, bacteria, yeast, and other microbial systems, with comparative host advantages. Engineering strategies include synthetic circuits, quorum sensing, and memory.
Cemile Elif Özçelik   +3 more
wiley   +1 more source

Toward Disease-Modifying Therapies in Type 1 Diabetes: Focus on Teplizumab. [PDF]

open access: yesDiabetes Care
Mathieu C   +6 more
europepmc   +1 more source

Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis

open access: green, 2003
Maaria Ikonen   +7 more
openalex   +2 more sources

Secretion of insulin-like peptide 3 in female cattle and expression of its receptor in oocyte and sperm

open access: yesSecretion of insulin-like peptide 3 in female cattle and expression of its receptor in oocyte and sperm
学位記番号:論獣医学第298号, 主査:川手 ...
openaire  

Recombinant Monoclonal Antibodies for Detecting the Tubulin Post‐Translational Modifications Glutamylation and Lysine‐40 Acetylation

open access: yesCytoskeleton, EarlyView.
ABSTRACT Post‐translational modifications (PTMs) to tubulin subunits in microtubule filaments are thought to comprise a component of the tubulin code that specifies microtubule functions in cell physiology and animal development. Acetylation of Lysine‐40 (K40) on α‐tubulin (αTub‐K40ac) and glutamylation of both α‐ and β‐tubulin are two tubulin PTMs of ...
Lynne Blasius   +6 more
wiley   +1 more source

Altered Glucagon Response to Oral Glucose in Individuals at Different Stages of Type 1 Diabetes Development.

open access: yesJ Clin Endocrinol Metab
Kontola H   +6 more
europepmc   +1 more source

A Systematic Review on Disease‐Modifying Therapies in Parkinsonian Disorders

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Parkinsonian disorders, including Parkinson's disease, Lewy body dementia, multiple system atrophy, and progressive supranuclear palsy, are progressive neurodegenerative conditions with no treatment options to slow disease progression. This systematic review provides an overview of evidence of disease‐modifying therapies that have been evaluated in ...
Pepijn P.N.M. Eijsvogel   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy